NASDAQ:IRTC iRhythm Technologies Q3 2025 Earnings Report $182.25 +0.45 (+0.25%) Closing price 10/20/2025 04:00 PM EasternExtended Trading$182.33 +0.08 (+0.04%) As of 10/20/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. ProfileEarnings HistoryForecast iRhythm Technologies EPS ResultsActual EPSN/AConsensus EPS -$0.36Beat/MissN/AOne Year Ago EPSN/AiRhythm Technologies Revenue ResultsActual RevenueN/AExpected Revenue$184.75 millionBeat/MissN/AYoY Revenue GrowthN/AiRhythm Technologies Announcement DetailsQuarterQ3 2025Date10/30/2025TimeAfter Market ClosesConference Call DateThursday, October 30, 2025Conference Call Time4:30PM ETConference Call ResourcesEarnings HistoryCompany Profile iRhythm Technologies Earnings HeadlinesiRhythm Technologies (IRTC) Leads Cardiac Monitoring Market with Zio Device, Freedom Capital Initiates CoverageOctober 20 at 7:51 AM | insidermonkey.comiRhythm Technologies, Inc. to Announce Third Quarter 2025 Financial Results on October 30October 16, 2025 | quiverquant.comQThis dark force is about to change everythingAn unstoppable force is reshaping America — one so powerful it’s already disrupting how we work, invest, and live. Porter Stansberry calls it The Final Displacement — a rare turning point that’s only happened four times in human history, each one redefining entire eras. His new documentary reveals why this shift could trigger both immense loss and unprecedented opportunity, and what you can do to prepare before it accelerates. | Porter & Company (Ad)iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025October 16, 2025 | globenewswire.comBTIG Research Forecasts Strong Price Appreciation for iRhythm Technologies (NASDAQ:IRTC) StockOctober 15, 2025 | americanbankingnews.comBTIG Maintains iRhythm Technologies (IRTC) Buy RecommendationOctober 14, 2025 | msn.comSee More iRhythm Technologies Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like iRhythm Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on iRhythm Technologies and other key companies, straight to your email. Email Address About iRhythm TechnologiesiRhythm Technologies (NASDAQ:IRTC), Inc. is a medical technology company that develops and commercializes wearable cardiac monitoring devices and associated data analytics services. Founded in 2006 and headquartered in San Francisco, California, the company’s flagship product is the Zio® patch, a discreet, single-use, continuous ECG recorder designed to monitor heart rhythms for up to 14 days. iRhythm’s digital diagnostics platform combines biosensor technology with proprietary algorithms to detect arrhythmias and streamline data interpretation for physicians. The Zio service is prescribed by cardiologists and other healthcare providers to aid in the diagnosis of atrial fibrillation, bradycardia, tachycardia and other rhythm disorders. After wearing the water-resistant patch, patients mail it back to iRhythm’s central lab, where recorded data are analyzed using the company’s AI-powered architecture. A comprehensive report, including annotated ECG strips and rhythm diagnosis, is delivered directly to the prescribing clinician, helping to guide treatment decisions. iRhythm primarily serves the United States market through partnerships with hospitals, clinics and diagnostic laboratories, and the company has been expanding its global footprint through strategic collaborations and regulatory approvals in select international markets. Leadership is headed by President and Chief Executive Officer Kevin King, who has overseen product innovation and process enhancements to support scalable growth. iRhythm continues to invest in research and development to extend its diagnostic platform into emerging areas of cardiovascular care and digital health.View iRhythm Technologies ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetGoldman Sachs Earnings Tell: Markets Seem OkayWhy Congress Is Buying Intuitive Surgical Ahead of Earnings3 Reasons to Buy Sprouts Farmers Market Ahead of EarningsTesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 Earnings Upcoming Earnings Intuitive Surgical (10/21/2025)Nasdaq (10/21/2025)Netflix (10/21/2025)Texas Instruments (10/21/2025)Citigroup (10/21/2025)Chubb (10/21/2025)Capital One Financial (10/21/2025)Danaher (10/21/2025)Elevance Health (10/21/2025)GE Aerospace (10/21/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
